Gavin J Churchyard

13PUBLICATIONS

85CO-AUTHORS

Foetal development and medicineEpidemiological methodsInnate immunityEpidemiological modellingMedical bacteriology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|May 16, 2026

Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial.

|Mar 17, 2026

Dynamics of Quantiferon-Gold Plus results in a large TB preventive treatment trial across three high-burden HIV/TB countries.

Belén Saavedra-Cervera, Dinis Nguenha, Violet Chihota

|Mar 05, 2026

Imprecision in tuberculosis infection outcomes: implications for non-inferiority vaccine trials.

Daniel J Grint, Richard G White, Gavin Churchyard

|Feb 18, 2026

Risk factors for immunological sensitization to Mycobacterium tuberculosis and progression to incident TB disease among HIV-uninfected adults in a high burden setting.

Humphrey Mulenga, Simon C Mendelsohn, Andrew Fiore-Gartland

|Feb 12, 2026

Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study.

Hira Tanvir, Rebecca A Clark, Tom Sumner

|Feb 09, 2026

Optimized Mass Spectrometry to Uncover M. tuberculosis Biomarkers in Extracellular Vesicles from Asymptomatic Tuberculosis Patients.

Luisa Maria Nieto Ramirez, Kimberly Shelton, John T Belisle

Pageof 3

Frequent Collaborators

Richard G White

Kogieleum Naidoo

Humphrey Mulenga

Thomas Scriba

Rebecca A Clark

Michèle Tameris

Mark Hatherill

Gerhard Walzl

Richard E Chaisson

Violet Chihota

Frequent Collaborators

Richard G White

Kogieleum Naidoo

Humphrey Mulenga

Thomas Scriba